Douglas L. Mann, MD, Michael A. Acker, MD, Mariell Jessup, MD, Hani N

Slides:

Advertisements

Similar presentations

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Advertisements

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

The American Heart Association

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Analysis of Survival in 300 High-Risk Patients up to 2

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Outcomes of Reintervention on the Autograft After Ross Procedure

Sustained Benefits of the CorCap Cardiac Support Device on Left Ventricular Remodeling: Three Year Follow-up Results From the Acorn Clinical Trial Randall.

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Douglas L. Mann, MD, Spencer H. Kubo, MD, Hani N

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Improved Mitral Valve Performance After Transapical Aortic Valve Implantation Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,

Dhaval Chauhan, MD, Alexis K

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial Ranjit John, MD, Yoshifumi Naka, MD,

Biventricular Conversion After Single Ventricle Palliation in Patients With Small Left Heart Structures: Short-Term Outcomes Brian T. Kalish, MD, Puja.

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Randomized Study of Mononuclear Bone Marrow Cell Transplantation in Patients With Coronary Surgery Qiang Zhao, MD, Yongxin Sun, MD, Limin Xia, MD, Anqing.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair Tianyu Zhou, MD, Jun Li, MD, PhD, Hao Lai, MD, PhD, Kai Zhu, MD,

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Long-Term Outcomes of the Mosaic Bioprosthesis

One-Year Results After Implantation of the CorCap for Dilated Cardiomyopathy and Heart Failure Giuseppe Speziale, MD, Giuseppe Nasso, MD, Felice Piancone,

Postoperative Recurrence of Mitral Regurgitation After Annuloplasty for Functional Mitral Regurgitation Lawrence S. Lee, MD, Michael H. Kwon, MD, Marisa.

Initial Clinical Experience With the Symphony Heart Assist System

Karam Nam, MD, Yoon Sang Park, MD, Won Ho Kim, MD, PhD

Ventricular constraint in severe heart failure halts decline in cardiovascular function associated with experimental dilated cardiomyopathy Jai S Raman,

Surgical Ventricular Restoration Procedure: Single-Center Comparison of Surgical Treatment of Ischemic Heart Failure (STICH) Versus Non-STICH Patients

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Survival Prediction in Patients Undergoing Open-Heart Mitral Valve Operation After Previous Failed MitraClip Procedures Stephan Geidel, MD, Peter Wohlmuth,

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Maria Kalliopi Konstantinidou, MD, PhD, Neil Moat, MD, PhD

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.

Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial Michael A. Acker, MD,

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Vasileios Kamperidis, MD, PhD, Suzanne E

Changes in right ventricular dimensions and performance after passive cardiac containment Alexander Lembcke, MD, Simon Dushe, MD, Steffen Sonntag, MD,

Long-Term Outcome of Arterial Switch Operation Conversion After Failed Senning/Mustard Procedure Takuya Maeda, MD, Takahiko Sakamoto, MD, Mitsugi Nagashima,

Ivo R. Henkens, MD, Alexander van Straten, MD, Martin J

Jerry Braun, MD, Nico R. van de Veire, MD, Robert J. M

Aortic Regurgitation With Markedly Reduced Left Ventricular Function Is Not a Contraindication for Aortic Valve Replacement Tsuyoshi Kaneko, MD, Julius.

Roni M. Jacobsen, MD, Michael G. Earing, MD, Garick D

Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation Morgan L. Brown,

Experience With Biventricular Intervention for Neonates With Mitral Valve Abnormalities in the Setting of Critical Left-Side Heart Obstruction Catherine.

Surgical Ventricular Restoration for Patients With Ischemic Heart Failure: Determinants of Two-Year Survival Tomasz G. Witkowski, MD, Ellen A. ten Brinke,

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy Atsushi Yamaguchi, MD, Hideo Adachi, MD, Koji Kawahito, MD, Seiichiro.

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Multiple Valve Surgery with Beating Heart Technique

Survival Benefit of Aortic Valve Replacement in Older Patients With Asymptomatic Chronic Severe Aortic Regurgitation Rami Turk, MD, Padmini Varadarajan,

Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Early and Midterm Outcomes for Tricuspid Valve Surgery After Left-Sided Valve Surgery Choung Kyu Park, MD, Pyo Won Park, MD, Kiick Sung, MD, Young Tak.

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Impact of Surgical Ventricular Restoration on Diastolic Function: Implications of Shape and Residual Ventricular Size Serenella Castelvecchio, MD, Lorenzo.

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Risk of Valve-Related Events After Aortic Valve Repair

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

David H. Harpole, MD, Stanley A. Gall, MD, Walter G. Wolfe, MD, J

Presentation transcript:

Clinical Evaluation of the CorCap Cardiac Support Device in Patients With Dilated Cardiomyopathy Douglas L. Mann, MD, Michael A. Acker, MD, Mariell Jessup, MD, Hani N. Sabbah, PhD, Randall C. Starling, MD, Spencer H. Kubo, MD The Annals of Thoracic Surgery Volume 84, Issue 4, Pages 1226-1235 (October 2007) DOI: 10.1016/j.athoracsur.2007.03.095 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Randomization, treatment, and vital status of patients in the Acorn trial. (CorCap [Acorn Cardiovascular]; MV = mitral valve.) The Annals of Thoracic Surgery 2007 84, 1226-1235DOI: (10.1016/j.athoracsur.2007.03.095) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier curves for freedom from major cardiac procedures (MCP) in both the cardiac support device treatment and control groups. The treatment group was significantly better than the control group (p = 0.01). The Annals of Thoracic Surgery 2007 84, 1226-1235DOI: (10.1016/j.athoracsur.2007.03.095) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Change in left ventricular (LV) structure in the cardiac support device (CSD) treatment and control groups. (A) Change in LV end-diastolic volume (LVEDV) (mL) from baseline. (B) change in LV end-systolic volume (LVESV) (mL) from baseline. (C) Change in LV ejection fraction (EF) (units) from baseline. (D) Change in LV sphericity index (ratio of LV long axis to LV short axis) at 3, 6, and 12 months. The Annals of Thoracic Surgery 2007 84, 1226-1235DOI: (10.1016/j.athoracsur.2007.03.095) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Change in quality of life scores in the cardiac support device (CSD) treatment and control groups. (A) Change in Minnesota Living with Heart Failure Questionnaire (MLHFQ) score from baseline; (B) change in Short Form-36 Questionnaire (SF-36) score from baseline at 3, 6, and 12 months. The Annals of Thoracic Surgery 2007 84, 1226-1235DOI: (10.1016/j.athoracsur.2007.03.095) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Appendix Fig 1 Graphic output: death or MCP. Sample display. (C = control; LVEDD = left ventricular end-diastolic dimension; MCP = major cardiac procedures; T = treatment). The Annals of Thoracic Surgery 2007 84, 1226-1235DOI: (10.1016/j.athoracsur.2007.03.095) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions